FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 64980-282 · HUMAN PRESCRIPTION DRUG · SUPPOSITORY

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207448
Dosage form / routeSUPPOSITORY · RECTAL
Active ingredientsMESALAMINE (1000 mg/1)
Marketing started20190605
Marketing ended20261031
Package count1

External sources

Source: openFDA. Public-domain (CC0).